Safety, Tolerability and Pharmacokinetics of AUT00206 in Patients With Schizophrenia, and Also Explores the Effects of AUT00206 on Relevant Central Biomarkers.
Clinical trial NCT03164876 · COMPLETED
Trial details
- NCT number
- NCT03164876
- Sponsor
- Autifony Therapeutics Limited
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-20
- Primary completion
- 2019-04-03
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.